Pontifax Management III G.P. (2011) Ltd. 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-18 06:16 am Purchase |
2024-03-14 | 13D | Eloxx Pharmaceuticals, Inc. ELOX |
Pontifax Management III G.P. (2011) Ltd. | 1,485,168 4.400% |
1,485,168 (New Position) |
Filing |
| 2021-05-21 4:05 pm Purchase |
2021-05-18 | 13D | Eloxx Pharmaceuticals, Inc. ELOX |
Pontifax Management III G.P. (2011) Ltd. | 186,520 8.660% |
6,816 (+3.79%) |
Filing |